Suppression of Placental Metallothionein 1 and Zinc Transporter 1 mRNA Expressions Contributes to Fetal Heart Malformations Caused by Maternal Zinc Deficiency
详细信息 查看全文
- 作者：Chaobin Liu (1)
Xiaoyu He (2) (3)
Xinru Hong (2) (3) (4)
Fenhong Kang (2)
Suqing Chen (1)
Qing Wang (5)
Xiaoqiu Chen (6)
Dian Hu (7)
Qinghua Sun (8) - 关键词：Zinc deficiency ; Heart malformations ; Fetus ; Metallothionein 1 ; Zinc transporter 1
- 刊名：Cardiovascular Toxicology
- 出版年：2014
- 出版时间：December 2014
- 年：2014
- 卷：14
- 期：4
- 页码：329-338
- 全文大小：871 KB
- 参考文献：1. Bentham, J., & Bhattacharya, S. (2008). Genetic mechanisms controlling cardiovascular development. / Annals of the New York Academy of Sciences, / 1123, 10-9. CrossRef
2. Tennstedt, C., Chaoui, R., Korner, H., & Dietel, M. (1999). Spectrum of congenital heart defects and extracardiac malformations associated with chromosomal abnormalities: Results of a seven year necropsy study. / Heart, / 82, 34-9. CrossRef
3. Botto, L. D., & Correa, A. (2003). Decreasing the burden of congenital heart anomalies: An epidemiologic evaluation of risk factors and survival. / Progress in Pediatric Cardiology, / 18, 111-21. CrossRef
4. Scheplyagina, L. A. (2005). Impact of the mother’s zinc deficiency on the woman’s and newborn’s health status. / Journal of Trace Elements in Medicine and Biology, / 19, 29-5. CrossRef
5. Lopez, V., Keen, C. L., & Lanoue, L. (2008). Prenatal zinc deficiency: Influence on heart morphology and distribution of key heart proteins in a rat model. / Biological Trace Element Research, / 122, 238-55. CrossRef
6. Jameson, S. (1976). Zinc and copper in pregnancy, correlations to fetal and maternal complications. / Acta Medica Scandinavica, / 593, 5-0.
7. Zhang, B. Y., Zhang, T., Lin, L. M., Wang, F., Xin, R. L., Gu, X., et al. (2008). Correlation between birth defects and dietary nutrition status in a high incidence area of China. / Biomedical and Environmental Sciences, / 21, 37-4. CrossRef
8. He, X., Hong, X., Zeng, F., Kang, F., Li, L., & Sun, Q. (2009). Zinc antagonizes homocysteine-induced fetal heart defects in rats. / Cardiovascular Toxicology, / 9, 151-59. CrossRef
9. Helston, R. M., Phillips, S. R., McKay, J. A., Jackson, K. A., Mathers, J. C., & Ford, D. (2007). Zinc transporters in the mouse placenta show a coordinated regulatory response to changes in dietary zinc intake. / Placenta, / 28, 437-44. CrossRef
10. Onosaka, S., & Cherian, M. G. (1982). The induced synthesis of metallothionein in various tissues of rats in response to metals. II. Influence of zinc status and specific effect on pancreatic metallothionein. / Toxicology, / 23, 11-0. CrossRef
11. Andrews, G. K., & Geiser, J. (1999). Expression of the mouse metallothionein-I and -II genes provides a reproductive advantage during maternal dietary zinc deficiency. / Journal of Nutrition, / 129, 1643-648.
12. Li, B., Tan, Y., Sun, W., Fu, Y., Miao, L., & Cai, L. (2013). The role of zinc in the prevention of diabetic cardiomyopathy and nephropathy. / Toxicology Mechanisms and Methods, / 23, 27-3. CrossRef
13. Wu, C. Y., Bird, A. J., Chung, L. M., Newton, M. A., Winge, D. R., & Eide, D. J. (2008). Differential control of Zapl-regulated genes in response to zinc deficiency in / Saccharomyces cerevisiae. / BMC Genomics, / 9, 370. CrossRef
14. Asano, N., Kondoh, M., Ebihara, C., Fujii, M., Nakanishi, T., Soares, M. J., et al. (2004). Expression profiles of zinc transporters in rodent placental models. / Toxicology Letters, / 154, 45-3. CrossRef
15. Liuzzi, J. P., Bobo, J. A., Lichten, L. A., Samuelson, D. A., & Cousins, R. J. (2004). Responsive transporter genes within the murine intestinal-pancreatic axis form a basis of zinc homeostasis. / Proceedings of the National Academy of Sciences of the United States of America, / 101, 14355-4360. CrossRef
16. Andrews, G. K., Wang, H., Dey, S. K., - 作者单位：Chaobin Liu (1)
Xiaoyu He (2) (3)
Xinru Hong (2) (3) (4)
Fenhong Kang (2)
Suqing Chen (1)
Qing Wang (5)
Xiaoqiu Chen (6)
Dian Hu (7)
Qinghua Sun (8)
1. Department of Obstetrics and Gynecology, Fujian Provincial Maternal and Child Health Hospital, Fuzhou, 350001, Fujian, China
2. Department of Obstetrics and Gynecology, Fuzhou General Hospital, 156 North Xihuan Road, Fuzhou, 350025, Fujian, China
3. Fuzhou Clinic Medical College, Fujian Medical University, Fuzhou, 350025, Fujian, China
4. Dongfang Affiliated Hospital of Xiamen University, Fuzhou, 350025, Fujian, China
5. Fuzhou Product Quality Monitoring Bureau, Fuzhou, 350025, Fujian, China
6. Fujian Central Station of Environmental Monitoring, 138 South Fufei Road, Fuzhou, 350003, Fujian, China
7. Department of Obstetrics and Gynecology, Changzheng Hospital, Second Military Medical University, Shanghai, 200433, China
8. Division of Environmental Health Sciences, College of Public Health, The Ohio State University, Columbus, OH, 43210-1240, USA - ISSN：1559-0259
文摘
Zinc has been implicated to have a protective role against heart malformations during fetal development. Metallothionein 1 (MT-1) and zinc transporter 1 (ZnT-1) are two major metabolic factors that are associated with zinc metabolism. The present work aimed to investigate the association of placental MT-1 and ZnT-1 expressions with fetal heart malformations resulting from maternal zinc deficiency. Sprague–Dawley female rats were randomly divided into five groups of extremely low-zinc, low-zinc, moderately low-zinc, marginally low-zinc and normal zinc (n?=?9-2), and were fed diets with controlled zinc content at 1.0?±?0.3, 8.4?±?1.8, 15.4?±?2.8, 22.4?±?4.1 and 29.4?±?5.3 [mean?±?standard deviation (SD)] mg of zinc/kg, respectively, from day 25 of preconception until day 19 of gestation. The female rats were bred, their fetuses were harvested at day 19 of gestation after killing the dams, and fetal hearts were morphologically examined. Zinc concentration and alkaline phosphatase (ALP) activity in maternal venous blood sera were tested, and MT-1 and ZnT-1 mRNA expressions in the placenta were assayed. Zinc concentrations and ALP activities in the blood were low in all zinc-deficient diet groups in a dose-dependent fashion. The incidences of heart malformations were increased, and the levels of placental MT-1 and ZnT-1 mRNA expressions were decreased in the extremely low-zinc, low-zinc and moderately low-zinc groups compared with the normal zinc group. Specifically, mRNA levels of placental MT-1 or ZnT-1 were significantly decreased and were lower than the specific threshold values in the fetuses with heart malformations but not in the fetuses without heart malformations in all the groups. These data indicate that maternal zinc deficiency resulted in an elevated incidence of fetal heart malformations, which was associated with significant decreases in placental MT-1 and ZnT-1 mRNA expressions to the levels below the threshold values that may be a crucial factor to determine the presence of fetal heart malformations.